1Role of apoptosis-inducing factor in perinatal hypoxic-ischemic brain injuryJuan Rodriguez, Tao Li, Yiran Xu, Yanyan Sun, Changlian Zhu205-2132Therapeutic potential of neuromodulation for demyelinating diseasesElliot H. Choi, Chioma Nwakalor, Nolan J. Brown, Joonho Lee, Michael Y. Oh, In Hong Yang214-2173Dysfunctional glia: contributors to neurodegenerative disordersMarta Sidoryk-W?grzynowicz, Lidia Stru?yńska218-2224Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophyllsMikhail A. Filippov, Olga G. Tatarnikova, Natalia V. Pozdnyakova, Vasily V. Vorobyov223-2335Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studiesClaudio Giuliano, Silvia Cerri, Fabio Blandini234-2416Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravisFrancisco J. Barrantes242-2467Hydrogel-based local drug delivery strategies for spinal cord repairRobert B. Shultz, Yinghui Zhong247-2538Altered physiology of gastrointestinal vagal afferents following neurotraumaEmily N. Blanke, Gregory M. Holmes, Emily M. Besecker254-2639Prospects for intelligent rehabilitation techniques to treat motor dysfunctionCong-Cong Huo, Ya Zheng, Wei-Wei Lu, Teng-Yu Zhang, Dai-Fa Wang, Dong-Sheng Xu, Zeng-Yong Li264-26910Microglia in neurodegenerative diseasesYu Xu, Ming-Zhu Jin, Ze-Yong Yang, Wei-Lin Jin270-28011Membrane progesterone receptors (mPRs/PAQRs) in Schwann cells represent a promising target for the promotion of neuroregenerationLuca F. Castelnovo, Peter Thomas, Valerio Magnaghi281-28212Nanoparticles as a tool to deliver drugs to the retina and brain: an updateQing You, Bernhard A. Sabel283-28413Stem cell heterogeneity and regenerative competence: the enormous potential of rare cellsEmily A.B. Gilbert, Cindi M. Morshead285-28614Gut microbiota: a potential therapeutic target for Parkinson's diseaseJosé Fidel Baizabal-Carvallo287-28815Novel Galectin-3 interactions involved in oligodendroglial differentiation make inroads into therapeutic strategies for demyelinating diseasesLaura Andrea Pasquini289-29016Oligodendrocytes in a dish for the drug discovery pipeline: the risk of oversimplificationVito Antonio Baldassarro, Luciana Giardino, Laura Calzà291-29317The role of NLRP3 inflammasome for microglial response to peripheral inflammationOlga Garaschuk294-29518Multi-omics insights into neuronal regeneration and re-innervationMuhammad Zain Chauhan, Sanjoy K. Bhattacharya296-29719Chemical biology: a toolbox to unlock neurochemical epigenetics?Dennis ?zcelik298-29920Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotectionMargarita Díaz-Guerra300-301 